Reveals a new binding site that may enhance neomorphic activity in the R132H variant of IDH1, suggesting potential therapeutic targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nandeshwar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: